TransMedics Group Inc vs United States Natural Gas Fund — how do they compare? TransMedics Group Inc trades at $86.5 (market cap $3.00B), while United States Natural Gas Fund trades at $10.07. The key difference: TransMedics Group Inc is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| TMDX | UNG | |
|---|---|---|
Market Cap | $3.00B | — |
Sector | Technology | Commodities - Energy |
52-Week High | $150.42 | $16.90 |
52-Week Low | $61.99 | $9.63 |
Enterprise Value | $3.39B | — |
Signals from Pluang's Aura AI — not financial advice
TransMedics Group (TMDX) trades at $88.27, down 1.9% on the day, with a bullish technical signal from moving averages but mixed earnings performance. The company reported strong 2025 results with $605M revenue and 31.4% net margin, though 2026 projections show margin compression. Recent news highlights growth initiatives in kidney transplantation and European markets, alongside ongoing legal investigations into fiduciary duties.
The stock offers upside to the $99.57 consensus price target, supported by analyst bullishness (69% buy ratings), but faces risks from margin pressure, legal scrutiny, and earnings misses. Revenue growth remains a key catalyst, though execution risks and investor sentiment headwinds warrant caution.
UNG trades at $10.46, down 0.95% today, with a bearish technical signal from moving averages and neutral oscillators. Support and resistance cluster tightly around $10-$11. The fund tracks natural gas futures, facing headwinds from high production and storage levels, while demand forecasts remain strong for 2026-2027 per EIA (2026-09-09).
Outlook hinges on natural gas price volatility; upside exists if demand outpaces supply, but risks include oversupply and geopolitical impacts. Investors face contango roll costs in futures-based ETFs, contrasting with equity alternatives like FCG.
Trailing returns across standard periods
Latest headlines on both assets
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →